Skip to main content

Table 3 Correlations between the changes in study outcomes and changes in EQ-5D index

From: The impact of antihypertensive treatment initiation on health-related quality of life and cardiovascular risk factor levels: a prospective, interventional study

Outcome r (95% CI)
Crude Adjusted*
Weight, kg 0.08 (− 0.11 to 0.27) 0.06 (− 0.13 to 0.25)
Waist, cm  − 0.07 (− 0.25 to 0.13)  − 0.13 (− 0.32 to 0.06)
Physical activity, FIT index 0.05 (− 0.14 to 0.23) 0.08 (− 0.11 to 0.26)
AUDIT-C score 0.02 (− 0.17 to 0.21)  − 0.01 (− 0.20 to 0.18)
Total cholesterol, mmol/l  − 0.05 (− 0.24 to 0.15) 0.01 (− 0.18 to 0.21)
LDL cholesterol, mmol/l  − 0.05 (− 0.25 to 0.15) 0.01 (− 0.19 to 0.21)
HDL cholesterol, mmol/l 0.10 (− 0.10 to 0.29) 0.16 (− 0.04 to 0.35)
Triglycerides, mmol/l  − 0.03 (− 0.23 to 0.17)  − 0.07 (− 0.27 to 0.13)
Fasting glucose, mmol/l  − 0.09 (− 0.29 to 0.11)  − 0.12 (− 0.31 to 0.08)
Office BP, mmHg   
SBP  − 0.13 (− 0.32 to 0.06)  − 0.02 (− 0.21 to 0.17)
DBP  − 0.13 (− 0.31 to 0.06)  − 0.11 (− 0.29 to 0.08)
  1. *Adjusted for baseline values of EQ-5D, age and sex
  2. AUDIT-C, alcohol consumption questions from the alcohol use disorders identification test (AUDIT); BP, blood pressure; DBP, diastolic blood pressure, EQ-5D, EuroQoL questionnaire of health-related quality of life; FIT index, Frequency-Intensity-Time (FIT) Index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood pressure